- Pharmaceutical
- Stem Cells Market
"Designing Growth Strategies is in our DNA"
Stem Cells Market Size, Share & Industry Analysis, By Cell Type (Embryonic Stem Cells (ESCs), Mesenchymal Stem Cells (MSCs), Adult Stem Cells, and Induced Pluripotent Stem Cells (iPSCs)), By Application (Research and Clinical), By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2024-2032
Last Updated: June 03, 2024 | Format: PDF | Report ID: FBI105138
- Segmentation
- Methodology
- Infographics
- Request Sample PDF
KEY MARKET INSIGHTS
The global stem cells market size was valued at USD 15.07 billion in 2023 and is projected to grow from USD 17.02 billion in 2024 to USD 56.15 billion by 2032, exhibiting a CAGR of 16.1% during the forecast (2024-2032). North America accounted for a market value of USD 8.00 billion in 2023, with a share of 53.09% in 2023.
Stem cells have the ability to develop into specialized cells in the body. Stem cell therapy is an emerging treatment option for several diseases. It is witnessing widespread adoption in terms of research and clinical applications globally. The registration of clinical trials has been increasing at a significant rate annually to meet the increasing demand for novel medicines due to the rising prevalence of chronic diseases. Surge in the number of clinical trials owing to increase in research initiatives in the pharmaceutical sector are the key factors driving the global stem cells market growth. The clinical trials involving human pluripotent stem cells have increased in the last several years.
- According to the data published by the U.S. National Institutes of Health (NIH) in September 2022, 90 clinical trials had been registered in 13 countries with more than 3000 participants in 2021. However, only the U.S., Japan, China, and the U.K. conducted human embryonic and induced pluripotent stem cell-based trials. Moreover, the U.S., China, and Japan had listed 78% (70 out of 90) of all trials across the world.
Researchers and clinicians in the market are involved in developing innovative stem cell-based products that support healing & repair function, and improve patients' quality of life. In addition, the widespread applications of stem cell products and their higher adoption for therapies globally are attracting market players to set up manufacturing facilities. This factor is positively influencing the global market growth.
The COVID-19 outbreak positively impacted the growth of the global market. The application of stem cell products in treating the novel Coronavirus had boosted its demand, resulting in an increase in clinical trials. However, in 2021, the market witnessed sluggish growth owing to the delay in clinical trials and challenges associated with stem cell products. Nevertheless, the market is projected to record a rapid CAGR over the forecast period due to the growth in investments and strong product pipelines.
Stem Cells Market Trends
Emergence of iPSCs as Alternative to ESCs to Drive Market Growth
The induced Pluripotent Stem Cell (iPSC) technology has made enormous progress in stem cell biology and regenerative medicine . iPSCs are cells derived from adult somatic cells and are further reprogrammed to obtain the pluripotency of ESCs (Embryonic Stem Cells). The ESCs' derivation involves destroying an embryo at the blastocyte stage, which has created ethical concerns. However, iPSCs involve only the genetic reprogramming of somatic cells, hence they are away from the ethical issue of destroying human embryos in research. This has driven the market growth and increased the applications of this technology, such as disease modeling, drug discovery, and cell therapy development.
- For instance, in June 2023, FUJIFILM Cellular Dynamics, a manufacturer of human iPSCs, announced the launch of its human iPSC-derived iCell Blood-Brain Barrier Isogenic Kit for scientists involved in drug discovery for neuroactive drugs. The kit has barrier integrity and can advance drug discovery, development, and medical research for Central Nervous System (CNS) disorders.
Furthermore, human iPSCs are a highly preferred option due to the elimination of animal models and fewer ethical implications associated with these products. The iPSC segment is experiencing rapid growth in the market owing to increased demand for vaccines , growing application portfolio through continuous R&D activities, and rising investments in the sector.
- For instance, in a research study published by the National Center for Biotechnology Information (NCBI) in April 2023, researchers confirmed the strong trend of studies using human induced PSCs (iPSCs). This trend has become more significant since the past few years. The same source further stated that, in 2019-2020, the number of iPSC-based studies was 25, and in 2021-2022, this number was calculated to be 23.
Request a Free sample to learn more about this report.
Stem Cells Market Growth Factors
Expanding Applications in Research and Therapeutics to Augment Market Growth
Stem cell products have diverse application areas, including research and development of novel therapies, such as regenerative medicine. Regenerative medicine is one of medical science's most recent branches. It helps in the restoration of normal functions in patients suffering from chronic diseases or severe injuries. Stem cells are gaining significant attention and adoption among researchers, scientists, and clinicians for the development of innovative therapies for various diseases as they are a promising cell source.
- For instance, a research study published in JACC Journals in March 2023 demonstrated the potential of Mesenchymal Precursor Cells (MPCs) in addressing chronic heart failure due to low Ejection Fraction (EF). This was one of the largest clinical trials conducted for this indication.
Furthermore, several factors, such as increasing acquisition & partnership agreements between key players and robust government funding to create novel solutions from these products are projected to drive the market growth over the forecast period.
- For instance, in July 2022, Bio-Techne acquired Namocell, a U.S.-based company offering consumables and instruments required for cell and gene therapy development, cell engineering, cell line development, single-cell genomics, antibody discovery, synthetic biology, and rare cell isolation.
Furthermore, the increasing incidence of diseases, such as neurological disorders, diabetes, and cancer, and growing government funding to accelerate research on these products are anticipated to drive market growth.
Focus of Key Players on Collaborations and Partnerships to Foster Research Activities Will Spur Market Growth
Recently, pharmaceutical companies have shown increased interest in stem cell products. The need for novel and better stem cell-based therapies for cardiac, autoimmune, and neurological disorders has resulted in an overall increase in the R&D activities of this market. The rising collaborations and partnerships between pharmaceutical and biotechnological companies are expected to boost stem cell research and treatment across the globe significantly.
- For instance, in July 2023, Pluristyx, Inc. announced its partnership with Stem Genomics. This partnership will evaluate the genomic stability of Pluristyx’s Pluripotent Stem Cell (PSC) lines using Stem Genomics’ iCS-digital PSC assay.
- Similarly, in July 2023, Cordlife Hong Kong Limited (Cordlife) and Hong Kong Regen MedTech Limited (HKRM), the partner companies of Hong Kong Science and Technology Parks Corporation (HKSTP), signed a collaboration agreement to enhance stem cell therapy. The companies aimed to co-launch a Mesenchymal Stem Cells (MSCs)-focused medical project.
Moreover, companies are also expanding their focus on increasing their product portfolio related to iPSCs due to their benefits in treating various diseases, which in turn, is projected to drive the growth of the global market over the forecast period.
RESTRAINING FACTORS
Ethical Concerns and Regulatory Complications Related to Stem Cell Research to Stifle Market Growth
Stem cell research offers great promise and hope for new treatments of diseases, such as spinal cord injury, diabetes, Parkinson's disease, and myocardial infarction. However, many obstacles and ethical controversies are associated with stem cell research. Human embryonic Stem Cell (hESC) research is ethically controversial as it involves the destruction of human embryos to create cell lines. In addition, arguments about the federal funding guidelines for research in human embryonic-based products and issues regarding the scientific purity, safety, and adequacy of consent of human embryonic stem cell lines are some of the factors hampering market growth. Moreover, serious bacterial infections were noticed with non-Food and Drug Administration (FDA)-approved umbilical cord blood-derived stem cell products.
- For instance, according to the data published by the California Department of Public Health in March 2019, infections were reported in persons who received the ReGen Series produced by Genentech, Inc. and distributed by Liveyon, LLC, as well as other non-FDA-approved umbilical cord blood-derived stem cell products.
Such health concerns and regulatory complications might hamper the growth of the market to a certain extent.
Stem Cells Market Segmentation Analysis
By cell type analysis.
Mesenchymal Stem Cells (MSCs) Segment Dominates owing to the Robust Demand for MSCs in Research Activities
Based on cell type, the market is segmented into Mesenchymal Stem Cells (MSCs), Embryonic Stem Cells (ESCs), Adult Stem Cells (ASCs), and induced Pluripotent Stem Cells (iPSCs) .
The Mesenchymal Stem Cells (MSCs) segment held a dominant global market share in 2023. The segment’s growth is due to the robust demand for MSCs in research activities to create promising regenerative and stem cell-based therapies. The high secretion profile and self-renewal ability of MSCs are highly valued in the research communities for angiogenesis, skin tissues, and skeletal tissue regeneration research. This factor is boosting the demand for MSCs in the global market.
- For instance, in May 2023, Regenerative Labs started a prospective study using Wharton's jelly tissue allografts for Temporomandibular disorder (TMD). Wharton's jelly is a gelatinous connective tissue in the umbilical cord, and is an abundant source of mesenchymal stem cells.
Furthermore, the iPSCs segment accounted for the second-highest market share in 2023 and is projected to record the fastest CAGR. Rapid developments in iPSCs to boost the joint activities in basic and translational research to develop potential disease models and therapies will augment the segment’s growth.
On the other hand, Embryonic Stem Cells (ESCs) were the commonly used cell types in research studies. For instance, in a research study published in the National Center for Biotechnology Information (NCBI) in April 2023, researchers stated that human Embryonic Stem Cells (ESCs) accounted for a significant portion of research studies.
By Application Analysis
Research Segment Leads Owing to Growing Applications of Stem Cells as Potential Cure
Based on application, the market is bifurcated into research and clinical. The research segment held a dominant share of the global market in 2023. Globally, research activities utilizing stem cells as a potential cure are increasing. Also, the need for organoid and disease models using these cells is growing to understand the development of various diseases. These factors can significantly boost the segment’s growth.
- For instance, in June 2023, the Weizmann Institute of Science published data on stem cell-based human embryo model generation to understand and develop new insights into the causes of congenital disabilities and genetic disorders. Such developments will boost the research segment’s growth during the forecast period.
Moreover, the clinical segment is anticipated to record the fastest CAGR over the forecast period. Promising developments in regenerative medicine for the treatment of damaged tissues, cancers, Alzheimer's disease, and rare diseases will substantially increase the stem cell culturing processes across the globe. The increased need for large batches of stem cells for therapeutic purposes is anticipated to fuel the segment growth during the forecast period.
To know how our report can help streamline your business, Speak to Analyst
By End-user Analysis
Pharmaceutical & Biotechnology Segment Accounts for the Highest Market Share Owing to the Extensive Ongoing Clinical Studies
Based on end-user, the market is segmented into hospitals, pharmaceutical & biotechnology companies, academic & research institutes, and others.
The pharmaceutical & biotechnology companies segment captured the largest stem cells market share in 2023. Extensive clinical studies conducted across the globe for the development of stem cell therapies to treat chronic and rare diseases and a notable shift from embryonic stem cell lines to induced pluripotent stem cells for research activities are factors increasing the demand for stem cell culturing products in the pharmaceutical & biotechnology industry.
- For instance, in August 2023, Cynata Therapeutics initiated a phase 2 clinical trial for an iPSC-derived Cymerus Mesenchymal Stem Cell (MSC) product to treat steroid-resistant acute graft-versus-host diseases. Thus, clinical studies across the globe will increase the use of reagents and stem cells, thereby propelling the segment’s growth.
The academic & research institutes segment is estimated to account for the highest CAGR during the forecast period. Growing demand and development of cures for various diseases will boost industry-academic collaborations. Also, investments by major players in academic & research institutes will accelerate the segment’s growth. Besides, rising initiatives by government bodies are also expected to drive the segment’s progress during the forecast period.
REGIONAL INSIGHTS
The market is analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America Stem Cells Market Size, 2023 (USD Billion)
To get more information on the regional analysis of this market, Request a Free sample
North America market size was valued at USD 8.00 billion in 2023. The region accounted for the largest market share due to its huge volume of research and development activities, rising approvals for stem cell therapies, and advanced product launches across the region.
- For instance, in May 2023, the Maryland Stem Cell Research (MSCRF) Commission announced over USD 14.1 million in funding to promote innovative research to advance and strengthen stem cell treatments and technologies in Maryland, U.S.
In addition, Europe is projected to record a significant growth rate over the forecast period owing to rising investments in R&D activities by leading companies to treat rare diseases.
The Latin America and the Middle East & Africa regions accounted for a comparatively lower share of the market in 2023 due to the less penetration of stem cell therapy research in these regions.
List of Key Companies in Stem Cells Market
Thermo Fisher Scientific, Merck KGaA, STEMCELL Technologies, and Miltenyi Biotec B.V. & Co. KG to Lead Market Growth
Thermo Fisher Scientific, Merck KGaA, STEMCELL Technologies, and Miltenyi Biotec B.V. & Co. are dominating the market. These companies are focusing on increasing production and expanding their product offerings for stem cell culturing and cell therapy through acquisitions and collaborations.
- For instance, in March 2023, Thermo Fisher Scientific Inc. opened its cell therapy plant in collaboration with the University of California, San Francisco (UCSF) at the UCSF complex.
Furthermore, companies, such as Bio-Techne, AcceGen, and Lonza are undertaking various initiatives, such as new product launches and acquisitions to strengthen their market presence. Other market players include Cellular Engineering Technologies, PromoCell GmbH, and MEDIPOST Co. Most of these companies are small & mid-sized, thus have a comparatively lower share and product offerings in the market.
LIST OF KEY COMPANIES PROFILED:
- PromoCell GmbH (Germany)
- AcceGen (U.S.)
- Bio-Techne (U.S.)
- Cellular Engineering Technologies (U.S.)
- Merck KgaA (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- Lonza (Switzerland)
- Miltenyi Biotec B.V. & Co. KG (Germany)
- STEMCELL Technologies (Canada)
KEY INDUSTRY DEVELOPMENTS:
- December 2023 - GenCure and the University of Texas at San Antonio (UTSA) collaborated to develop cellular therapy products, services, and testing.
- August 2023 - BlueRock Therapeutics LP and bit.bio signed an agreement for the discovery, development, and manufacturing of iPSC-derived regulatory T cells (Tregs) which can be used for therapeutic purposes.
- July 2023 - PromoCell GmbH launched the PromoExQ MSC Growth Medium XF for in-vitro expansion of human Mesenchymal Stem Cells (hMSCs) in a regulated environment to consistently grow and maintain multipotent hMSCs.
- July 2023 - Pluristyx, Inc. partnered with Stem Genomics. This partnership will evaluate the genomic stability of Pluristyx’s Pluripotent Stem Cell (PSC) lines using Stem Genomics’ iCS-digital PSC assay.
- June 2023 - FUJIFILM Cellular Dynamics, a manufacturer of human induced Pluripotent Stem Cells (iPSCs), announced the launch of its human iPSC-derived iCell Blood-Brain Barrier Isogenic Kit for scientists involved in drug discovery for neuroactive medicines. The kit has barrier integrity and can advance drug discovery, development, and medical research for Central Nervous System (CNS) disorders.
- June 2023 - Lonza collaborated with Vertex Pharmaceuticals Incorporated to produce stem cell-derived, fully differentiated insulin-producing islet cell therapy for Type 1 Diabetes patients. The therapy is under investigation by Vertex Pharmaceuticals.
- May 2023 - ScaleReady USA, a joint venture of Bio-Techne, collaborated with Cellular Origins. Through the collaboration, ScaleReady USA will automate the cell and gene therapy manufacturing processes using a cellular-based robotic system.
REPORT COVERAGE
An Infographic Representation of Stem Cells Market
To get information on various segments, share your queries with us
The report offers a detailed analysis and overview of the market. It focuses on key aspects, such as competitive landscape, leading cell types, applications, end-users, and regions. Moreover, it offers insights into the market drivers, trends, dynamics, and other key insights. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the growth of the market in recent years.
REPORT SCOPE & SEGMENTATION
| 2019-2032 |
| 2023 |
| 2024 |
| 2024-2032 |
| 2019-2022 |
| CAGR of 16.1% from 2024-2032 |
| Value (USD Billion) |
|
|
| |
| |
|
Frequently Asked Questions
Fortune Business Insights says that the global market size was valued at USD 15.07 billion in 2023 and is projected to reach USD 56.15 billion by 2032.
In 2023, the North America market value stood at USD 8.00 billion.
Registering a CAGR of 16.1%, the market will exhibit steady growth during the forecast period of 2024-2032.
By cell type, the Mesenchymal Stem Cells (MSCs) segment is expected to be the leading segment in the market during the forecast period.
Rise in the number of clinical trials leading to innovative product launches and strong focus of key players on collaborations and partnerships are major factors driving the growth of the market.
Thermo Fisher Scientific, Merck KGaA, STEMCELL Technologies, and Miltenyi Biotec B.V. & Co. KG are major players in the global market.
North America dominated the market share in 2023.
Emergence of iPSCs as an alternative to ESCs (Embryonic Stem Cells) is a key trend in the market.
Seeking Comprehensive Intelligence on Different Markets? Get in Touch with Our Experts
- STUDY PERIOD: 2019-2032
- BASE YEAR: 2023
- HISTORICAL DATA: 2019-2022
- NO OF PAGES: 190
Personalize this Research
- Granular Research on Specified Regions or Segments
- Companies Profiled based on User Requirement
- Broader Insights Pertaining to a Specific Segment or Region
- Breaking Down Competitive Landscape as per Your Requirement
- Other Specific Requirement on Customization
Healthcare Clients
Related Reports
- Allogeneic Stem Cells Market
- Induced Pluripotent Stem Cells Market
- Blood Cell Separation Market
- Regenerative Medicine Market
Client Testimonials
“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”
“Thanks a million. The report looks great!”
“Thanks for the excellent report and the insights regarding the lactose market.”
“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”
“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”
“Kudos to your team. Thank you very much for your support and agility to answer our questions.”
“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”
“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”
“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”
“We received the below report on the U.S. market from you. We were very satisfied with the report.”
“I just finished my first pass-through of the report. Great work! Thank you!”
“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”
“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”
“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”
Get in Touch with Us
+1 424 253 0390 (US)
+44 2071 939123 (UK)
+91 744 740 1245 (APAC)
[email protected]
- Request Sample
Sharing this report over the email
The global stem cells market size was valued at $15.07 billion in 2023 & is projected to grow from $17.02 billion in 2024 to $56.15 billion by 2032
Read More at:-
Stem Cell Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
The Report Covers Stem Cell Therapy Market Key Players. It is Segmented by Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, and Other Product Types), Application (Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders, and Other Applications), Treatment Type (Allogeneic Stem Cell Therapy, Auto Logic Stem Cell Therapy, and Syngeneic Stem Cell Therapy), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Values are Provided in Terms of (USD).
Stem Cells Market Size
Single User License
Team License
Corporate License
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 12.40 Billion |
| Market Size (2029) | USD 18.5 Billion |
| CAGR (2024 - 2029) | 10.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Global Stem Cell Market Analysis
The Global Stem Cell Market size is estimated at USD 12.40 billion in 2024, and is expected to reach USD 18.5 billion by 2029, growing at a CAGR of 10.20% during the forecast period (2024-2029).
Increased awareness about umbilical stem cells, growing demand for regenerative treatment options, and rising research and development initiatives to develop stem cell therapies are some of the major factors expected to drive the global market. In addition, increasing funding/grants for developing stem cell therapies is another factor projected to support the industry's expansion.
Increasing awareness about stem cells and their applications in advanced therapeutics like regenerative medicine and stem cell therapies is one of the major drivers of the market. For instance, according to an article published by Inflammation and Regeneration in December 2023, there is an increase in awareness levels of stem cells and their applications among people, and stem cells isolated from the umbilical cord are the effective off-the-shelve sources for cell and gene therapies in regenerative medicine and immunotherapies. Thus, such applications of stem cells in developing advanced therapeutics are key factors driving market growth.
In addition, the increase in the prevalence of chronic diseases and the growing implication of regenerative stem cell therapies in chronic diseases is another factor expected to support industry growth. For instance, according to a journal published by the American Heart Association, in March 2023, there were around 56.19 million heart failure cases globally. Thus, such an alarming increase in the burden of chronic diseases is expected to foster demand for innovative regenerative therapies for heart diseases, which, in turn, is expected to accelerate market growth.
The increased burden of chronic diseases has facilitated research efforts in regenerative stem cell therapy to develop promising therapeutics for such diseases. For instance, in December 2023, researchers from the Mayo Clinic and international collaborators demonstrated the effective role of stem cell-based regenerative therapy in advanced heart failure.
In January 2024, a stem cell therapy developed by UC Davis Health researchers for Crohn’s disease showed promising effects in preclinical trials. Thus, increased research efforts in the stem cell therapy are projected to facilitate industry expansion during the forecast period.
Moreover, the increased funding/grants to develop promising stem cell-based therapeutics are further projected to support the market growth. For instance, in January 2024, CellVoyant received funding of GBP 7.6 million (USD 9.49 million) from Octopus Ventures to boost its efforts to develop advanced stem cell therapies for managing several life-threatening conditions. Similarly, in February 2023, the National Institutes of Health granted USD 2.5 million to the research team of Purdue University to accelerate their stem cell research. Thus, such increased funding activities are anticipated to cater to industry expansion.
Several strategic initiatives market players undertake are further projected to spur market growth. For instance, in April 2023, Gamida Cell Ltd, a cell therapy leader, announced US FDA approval of Omisirge, an allogeneic cell therapy for treating pediatric patients and adults with hematologic malignancies. This approval will likely increase stem cell transplant access and improve patient outcomes. Thus, such initiatives will likely foster market expansion during the forecast period.
Thus, owing to the abovementioned factors, such as the growing demand for regenerative medicine, increased burden of chronic diseases, the growing role of stem cells in the management of chronic disease, and increasing grants/funding for stem cell therapeutics are expected to offer significant growth for the market during the forecast period. However, expensive procedures, regulatory complications, and ethical and moral frameworks may hinder the market's growth.
Global Stem Cell Market Trends
The oncology disorders segment is expected to exhibit the fastest growth rate during the forecast period.
The alarming increase in the burden of cancer globally, growing demand for innovative treatment options, the proven role of stem cell therapies in cancer treatment, and several strategic initiatives undertaken by industry participants are projected to augment segment uptake during the forecast period.
The increase in the burden of cancer and malignancies is expected to foster segment uptake over the coming years. For instance, according to the February 2024 updated data of Cancer Australia, the number of kidney cancer cases diagnosed ramped from 4,552 in 2022 to 4.600 people in 2023. Kidney cancer is the seventh most commonly diagnosed cancer in Australia, and it is estimated that one in 65 people will be diagnosed with the condition. Thus, the accelerating burden of cancer is expected to augment the demand for cell therapies like stem cell therapies for the effective management of cancer.
In addition, in recent years, stem cells have been used effectively in blood replenishment and immuno-reconstitution after cancer treatment. Also, these cells have gained remarkable traction across healthcare professionals for their role as a modality for delivering anti-tumor agents and their implication in tissue regeneration. A significant number of entities have reported positive outcomes of implementing this mode of tumor treatment. For instance, according to October 2023 data from the DVC Stem (Da Vinci Wellness Center), stem cells have shown promising outcomes in cancer, and approximately 87.5% of people realized improvement in their condition.
Similarly, in May 2023, a senior hematologist from Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, demonstrated stem cells' role in managing blood cancers and emphasized their roles in successful treatments. Thus, the evolving landscape of stem cell therapies in cancer and healthcare professionals' higher adoption of stem cell implants will likely cater to segment growth during the forecast period.
Several strategic initiatives market players undertake are further projected to augment segment growth during the forecast period. For instance, in October 2022, Bristol Myers Squibb (BMS) and Century Therapeutics formed a research collaboration to manufacture and commercialize four iPSC-derived (induced pluripotent stem cell) T-cell or natural killer cell programs for solid tumors and hematologic malignancies. Thus, such initiatives will likely foster segment growth during the forecast period.
Thus, owing to the abovementioned factors, such as the higher burden of cancer, growing demand for innovative therapeutics, and several strategic initiatives undertaken by the market players, segment growth is expected to propel during the forecast period.
North America is Expected to Hold a Significant Share in the Stem Cell Market During The Forecast Period
North America is projected to exhibit lucrative growth during the forecast period amid an increase in the prevalence of chronic diseases, growing research in stem cell therapies, the growing uptake of regenerative medicine in the region, and the region's supportive regulatory framework.
The increase in the burden of cancer in the United States is expected to fuel market growth. For instance, according to the American Cancer Society, the prevalence of mouth cancer is increasing in the country, and the country was about to report 15,490 mouth cancer cases in 2024 compared to 14,820 in 2023. Thus, the rising number of cancer cases is projected to fuel demand for advanced cancer therapies, which, in turn, will augment demand for stem cell therapies during the forecast period.
The rising emphasis on understanding stem cells' roles in cancer management has attracted researchers to develop cell-based cancer therapies. For instance, in January 2022, scientists from Cedars-Sinai demonstrated the role of stem cell therapies in cancer and their importance in improving cancer treatment.
Similarly, in December 2022, the City of Hope, a leader in stem cell medicine, and its Alpha Stem Cell Clinic received a USD 8 million grant from the California Institute of Regenerative Medicine to accelerate its role in regenerative medicine and cancer. Thus, such increased research efforts are likely to support regional market growth.
Also, a supportive regulatory framework coupled with rising demand for advanced therapeutics further fosters the regional market. For instance, in September 2023, the US Food and Drugs Administration approved motixafortide for use with filgrastim to prepare for a stem cell transplant. The approval is based on positive clinical trial results. In addition, in April 2023, the USFDA approved Omisirge, an allogeneic stem cell transplant therapy in the United States.
Thus, the factors mentioned above, such as North America's higher burden of chronic diseases, increasing research in stem cell therapeutics, and growing uptake of regenerative medicine in the region, are projected to accelerate regional market growth during the forecast period.
Global Stem Cell Industry Overview
The stem cell market is highly competitive and consists of several major players. In terms of market share, a few of the major players dominate the market. Major market players such as Thermo Fisher Scientific Inc., Sigma Aldrich (a subsidiary of Merck KGaA) BD, and Stem Cell Technologies are present. The major players' product advancements and improvements in stem cell technology are also increasing the competitive rivalry.
Stem Cells Market Leaders
Stemcell Technologies Inc.
Merck KGaA (Sigma Aldrich)
Thermo Fisher Scientific Inc.
STEMCELL Technologies.
*Disclaimer: Major Players sorted in no particular order
Global Stem Cell Market News
- April 2024: The Agency for Science, Technology, and Research in Singapore and SCG Cell Therapy (SCG) collaborated to advance the manufacturing of induced pluripotent stem cells (iPSC) that meet good manufacturing practices (GMP) standards.
- June 2023: StemCyte signed a cooperation agreement with a US-based company that develops allogeneic genetically modified CAR-NK cells using umbilical cord blood. Under this agreement, StemCyte has agreed to supply raw materials required for allogeneic cell therapy product development.
Stem Cells Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Demand For Stem Cell Banking
4.2.2 Increasing Prevalence Of Chronic Disorders
4.2.3 Ongoing Developments In Regenerative Medicine
4.2.4 Rising Funds For Accelerating Stem Cell Research
4.3 Market Restraints
4.3.1 Expensive Procedures
4.3.2 Regulatory Complications and Ethical and Moral Framework
4.4 Industry Attractiveness- Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Product Type
5.1.1 Adult Stem Cell
5.1.2 Human Embryonic Cell
5.1.3 Pluripotent Stem Cell
5.1.4 Other Product Types
5.2 By Application
5.2.1 Neurological Disorders
5.2.2 Orthopedic Treatments
5.2.3 Oncology Disorders
5.2.4 Injuries and Wounds
5.2.5 Cardiovascular Disorders
5.2.6 Other Applications
5.3 By Treatment Type
5.3.1 Allogeneic Stem Cell Therapy
5.3.2 Autologic Stem Cell Therapy
5.3.3 Syngeneic Stem Cell Therapy
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 United Kingdom
5.4.2.2 Germany
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.2 Pluri Inc
6.1.3 Thermo Fisher Scientific Inc.
6.1.4 Takara Bio Inc
6.1.5 Merck KGaA
6.1.7 STEMCELL Technologies.
6.1.8 AllCells LLC
6.1.9 Miltenyi Biotec
6.1.10 International Stem Cell Corporation
6.1.11 ReNeuron Group PLC
6.1.12 Bio-Techne
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Global Stem Cell Industry Segmentation
As per the scope of the report, stem cells are biological cells that can differentiate into other types of cells. Additionally, various types of stem cells are used for therapeutic purposes. With multiple applications at the clinical stage for various diseases, these are being explored extensively by many biopharmaceutical companies in recent times. The stem cells market is segmented by product type, application, treatment type, and geography. By product type, the market is segmented as adult stem cells, human embryonic cells, pluripotent stem cells, and other product types. By application, the market is segmented as neurological disorders, orthopedic treatments, oncology disorders, injuries and wounds, cardiovascular disorders, and other applications. By treatment type, the market is segmented as allogeneic stem cell therapy, auto-logic stem cell therapy, and syngeneic stem cell therapy. The report also covers the market sizes and forecasts for the stem cells market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).
| By Product Type | |
| Adult Stem Cell | |
| Human Embryonic Cell | |
| Pluripotent Stem Cell | |
| Other Product Types |
| By Application | |
| Neurological Disorders | |
| Orthopedic Treatments | |
| Oncology Disorders | |
| Injuries and Wounds | |
| Cardiovascular Disorders | |
| Other Applications |
| By Treatment Type | |
| Allogeneic Stem Cell Therapy | |
| Autologic Stem Cell Therapy | |
| Syngeneic Stem Cell Therapy |
| Geography | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stem Cells Market Research FAQsHow big is the global stem cell market. The Global Stem Cell Market size is expected to reach USD 12.40 billion in 2024 and grow at a CAGR of 10.20% to reach USD 18.5 billion by 2029. What is the current Global Stem Cell Market size?In 2024, the Global Stem Cell Market size is expected to reach USD 12.40 billion. Who are the key players in Global Stem Cell Market?Stemcell Technologies Inc., Merck KGaA (Sigma Aldrich), Thermo Fisher Scientific Inc., Pluri Inc and STEMCELL Technologies. are the major companies operating in the Global Stem Cell Market. Which is the fastest growing region in Global Stem Cell Market?Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Which region has the biggest share in Global Stem Cell Market?In 2024, the North America accounts for the largest market share in Global Stem Cell Market. What years does this Global Stem Cell Market cover, and what was the market size in 2023?In 2023, the Global Stem Cell Market size was estimated at USD 11.14 billion. The report covers the Global Stem Cell Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Stem Cell Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. What are the key challenges faced in the Stem Cell Therapy Market?The key challenges faced in the Stem Cell Therapy Market are a) Strict regulations and lengthy approval processes can delay market entry for new stem cell therapies b) Moral and religious debates surrounding the use of embryonic stem cells can hinder research and development Our Best Selling Reports
Stem Cell Industry ReportThe stem cell therapy market is experiencing significant growth, powered by the increasing prevalence of chronic diseases worldwide and advancements in regenerative medicine. Mesenchymal stem cell therapy is becoming increasingly important for treating various inflammatory, degenerative, and autoimmune diseases due to its regenerative and immunoregulatory capabilities. The market, divided into segments such as oncology and orthopedics, sees a notable demand in the orthopedic sector due to the aging population. Hospitals are leading end-users, due to global government efforts to boost healthcare infrastructure. Nonetheless, ethical issues related to embryonic stem cells pose challenges, which are somewhat mitigated by the emergence of induced pluripotent stem cells (iPSCs) that circumvent socio-ethical concerns. Despite technical challenges in manufacturing, the allogeneic stem cell therapy segment remains dominant. Geographically, North America holds a significant market share while the Asia Pacific region shows promising growth, driven by widespread adoption of stem cell therapies. With continuous R&D and government support, the market offers ample opportunities for innovation and growth. Get a sample of this industry analysis as a free report PDF download. Stem Cell Market Report Snapshots
Please enter a valid email id! Please enter a valid message!  Global Stem Cell Market Get a free sample of this report Please enter your name Business Email Please enter a valid email Please enter your phone number Get this Data in a Free Sample of the Global Stem Cell Market Report Please enter your requirement  Thank you for choosing us for your research needs! A confirmation has been sent to your email. Rest assured, your report will be delivered to your inbox within the next 72 hours. A member of our dedicated Client Success Team will proactively reach out to guide and assist you. We appreciate your trust and are committed to delivering precise and valuable research insights. Please be sure to check your spam folder too. Sorry! Payment Failed. Please check with your bank for further details. Add Citation APA MLA Chicago ➜ Embed Code X Get Embed Code Want to use this image? X Please copy & paste this embed code onto your site: Images must be attributed to Mordor Intelligence. Learn more About The Embed Code X Mordor Intelligence's images may only be used with attribution back to Mordor Intelligence. Using the Mordor Intelligence's embed code renders the image with an attribution line that satisfies this requirement. In addition, by using the embed code, you reduce the load on your web server, because the image will be hosted on the same worldwide content delivery network Mordor Intelligence uses instead of your web server. 
 Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), by Application, by Technology, by Therapy, by End Use, by Region, and Segment Forecasts, 2022-2030 
Table of ContentsCompanies mentioned, methodology, related topics, related reports.
Stem Cells Market Report Highlights
Table Information
 Global Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Application, End-user - Forecast 2024-2030
 Global Human Embryonic Stem Cells Market by Type (Pluripotent Stem Cells, Totipotent Stem Cells, Unipotent Stem Cells), Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering), End-User - Forecast 2024-2030 Global Human Embryonic Stem Cell Market Analysis & Forecast 2024-2034: Market By Application; By End-user; and By Region
 Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report Human Embryonic Stem Cells - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
ASK A QUESTION We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day. Request a Quote YOUR ADDRESS YOUR DETAILS PRODUCT FORMAT
DOWNLOAD SAMPLE Please fill in the information below to download the requested sample.
No products in the cart. 
Stem Cell Market Stem Cells Market Size, Share, Trends and Growth Report – Global Opportunities & Forecast, 2023-2030Stem Cell Market was valued at USD 12.1 billion in 2022 and is forecast to touch USD 27.5 billion in 2030, and the market is expected to grow at a CAGR of 10.8% from 2023-2030.  Overview of the Stem Cell Market ReportStem cells can also refer to specialized human cells that can reform many different cells from brain cells to muscle cells. They are found in bone marrow, brain, blood vessels, teeth, skin, among others. They have no specific function in the body but helps in faster recovery and treatment and bring versatility with healthier treatment. With the increasing number of clinical trials, the stem cell industry is anticipated to expand over the period of time. To have an edge over the competition by knowing the market dynamics and current trends of “Stem Cell Market”, request for Sample Report here Market DynamicStem cell market overview. The stem cell market is experiencing robust growth due to the increase in number of clinical trials across the globe. According to “national Library of Medicine”, the number of clinical trials registered in 2015 were 205,344 and by the end of April 2021, the number has reached to 373,420, which have substantially contributed to the growth of the market. In addition, the stem cell industry has gained importance with the support of government initiatives coupled with the increasing awareness about the advantages of stem cell storage among the people, which has pushed the growth of the market. For instance, in April 2021, the “Australian Government Department of Health”, launched a “Stem Cell Therapies Mission”, in which US$ 150 million will be invested over 9 years for Australians effective treatment, which will strengthen the market. In addition, increasing focus on the treatment of neurological disorders has majorly contributed to expanding the stem cell market. For instance, according to WHO around 7.1% of the total disease burden is neurological and cardiovascular disease, which can be treated by stem cell therapy. Restraint in the Stem Cell MarketOn the contrary, complications in unclear regulatory guidelines for commercialization and preservation of stem cells are expected to hamper the market’s growth. Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report Product – Segment AnalysisBased on the product, adult stem cells is expected to dominate the market over the forecast period. The factors contributing to adult stem cells’ growth are tumorigenesis, immune rejection, and minimal controversial issues concerning ethics. In addition, an increasing number of clinical trials have shifted the paddles for the market, leading to the growth of the market.  Application – Segment AnalysisBased on the application, regenerative medicine is expected to grow at a higher CAGR in the market over the forecast period. This is due to the rising number of approvals for different targeted diseases, which has propelled the market. For instance, in 2020 Government of Canada has announced that they will invest US$ 6.9 million in stem cell research which is likely to surge the growth of the market. In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here Regional – Segment Analysis:North America is expected to dominate the global stem cell market over the forecast period. This is due to the strong promotion for the use of cellular therapies for emerging diseases, which has surged the demand for the therapy in United States and Canada. For instance, in 2020 FDA approved a clinical trial that used umbilical cord-derived MSCs for inhibition of the life-menacing lung inflammation in COVID-19 patients, coupled with the strong reimbursement policies in the U.S. leading to the robust growth of the market.  Top Market PlayersVarious notable players operating in the market, include, Advanced Cell Technology, Inc., STEMCELL Technologies, Inc., BioTime, Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, PromoCell GmbH, Lonza, Kite Pharma, Cellartis AB, Angel Biotechnology, among others. Key Developments:
Segments Covered in the Report:The global stem cell market has been segmented based on product, application, technology and regions. Based on product, the market is segmented into adult stem cells (ASCs), human embryonic stem cells, induced pluripotent stem cells (Ipscs) and very small embryonic like stem cells. Based on application, the market is segmented into regenerative medicine and drug discovery and development. Based on technology, the market is segmented into cell acquisition, cell production, cryopreservation and expansion and sub-culture. For detailed scope of the “Stem Cell Market” report request a Sample Copy of the report Key questions answered in this research report:
Market SegmentationGlobal stem cell market by product.
Global Stem Cell Market by Application
Global Stem Cell Market by Technology
Global Stem Cell Market by RegionNorth america stem cell market (option 1: as a part of the free 25% customization).
Europe Stem Cell Market (Option 2: As a part of the free 25% customization)
Asia-Pacific Stem Cell Market (Option 3: As a part of the free 25% customization)
RoW Stem Cell Market (Option 4: As a part of the free 25% customization)
Major Players Operating in the Stem Cell (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)
Licensing Options Single-User License: The report is used by the purchaser (One Individual) only Multi-User License: Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only Corporate License: Report is shared with unlimited user (employees) of the purchasing corporation only$ 4,499.00 – $ 6,649.00 Why GMI Research
Username or email address * Login Remember me Lost your password? 
Stem Cells Market: By Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others), By Application (Regenerative Medicine (Oncology, Hematology, Orthopedics, Neurological Disorders, Cardiovascular and Myocardial Infraction, Diabetes, Injuries & Wounds, Liver Disorders, Others), Drug Discovery & Development), By Therapy Area (Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Syngeneic Stem Cell Therapy), By Technology Type (Cell Acquisition (Umbilical Blood Cord, Bone Marrow Harvest, Apheresis), By Cell Production (Therapeutic Cloning, In-Vitro Fertilization, Cell Culture, Isolation), Cryopreservation, Expansion and Cell Culture), and Geography Purchase OptionStem Cells Market size was valued at USD 17.12 billion by 2023 and is poised to grow at a CAGR of 8.6% from 2024 - 2030. owing to increase in prevalence of target chronic diseases and higher adoption of technological advancements coupled with rise in the economy and per capita expenditure are expected to drive the growth of the market. Moreover, rising investments in R&D owing to increased demand for stem cell production for potential investigation in disease management and cellular therapies are also recognized as the next major advancements in transforming healthcare. Additionally, Market players are expanding their cellular therapy portfolio understanding the future potential of the segment which fuels the growth of the market. However, expensive procedures for the development of stem cell therapies and regulatory complications restrain the growth of the market. Global stem cell market is surging due to increased approvals and strategic collaborations among the market players to strengthen their position different regions of the globe. For instance, Stem Cells Market Key Developments:
Key Developments: --> |